Business

March 5, 2014 10:51 AM

Pozen reports narrower loss in fourth quarter

Pozen reported a narrower net loss in the fourth quarter thanks to revenue from its arthritis drug and the licensing of its its experimental cardiovascular treatment.

Related content

Comments

Videos

Today's Market

Nasdaq
Powered by Barchart

Editor's Choice Videos

Raleigh Top Jobs

View All Top Jobs